Current:Home > MarketsNoah Lyles withdraws from Diamond League meet in Monaco to focus on Olympic training -ProWealth Academy
Noah Lyles withdraws from Diamond League meet in Monaco to focus on Olympic training
View
Date:2025-04-17 19:25:02
Defending 100 and 200 world champion Noah Lyles won’t be on the track this week in Monaco.
Lyles withdrew from the Friday's Wanda Diamond League competition. In a statement obtained by USA TODAY Sports, Lyles said he’s decided to stay home and continue to train in Florida.
“I'm sorry to announce that I've withdrawn from this Friday's Meeting Herculis EBS in Monaco," Lyles said. "The meet is one of my favorites to compete in, and Monaco is one of my favorite places that my career has taken me to."
My coach, my entire team and I are very pleased with what we were able to achieve at the US Olympic Trials in Eugene, however, in order to put myself in the best possible position to succeed in Paris, we have decided to spend an extra week at our training base in Florida before traveling to Europe. I'll miss competing there on Friday, but I look forward to returning to race in Monaco next year."
Lyles was entered to compete in the 200 in Monaco. Joshua Hartmann (Germany), Andrew Hudson (Jamaica), Alexander Ogando (Dominican Reupublic), Tarsis Orogot (Uganda), William Reais (Switzerland), Letsile Tebogo (Botswana) and Filippo Tortu (Italy) are the remaining athletes on the Wanda Diamond League 200 start list.
Meet Team USA: See which athletes made the U.S. Olympic team and where they are from
Wanda Diamond League is one of the final track and field events before the Paris Olympics.
Lyles won the 100 and 200 at the U.S. Olympic trials to qualify for the Paris Games. He ranks No. 1 in the world in the 200 and No. 4 in the world in the 100. However, he’s set to enter to Paris Olympics as a gold-medal favorite in both events.
Carl Lewis was the last American man to win the 100-200 sprint double, doing so at the Los Angeles Olympics in 1984.
Lyles is also expected to be a member of Team USA’s 4x100-relay team in Paris.
The USA TODAY app gets you to the heart of the news — fast. Download for award-winning coverage, crosswords, audio storytelling, the eNewspaper and more.
veryGood! (364)
Related
- Meta donates $1 million to Trump’s inauguration fund
- Keeping Up With the Love Lives of The Kardashian-Jenner Family
- Huntington's spreads like 'fire in the brain.' Scientists say they've found the spark
- How many miles do you have to travel to get abortion care? One professor maps it
- Don't let hackers fool you with a 'scam
- Are masks for the birds? We field reader queries about this new stage of the pandemic
- Peru is reeling from record case counts of dengue fever. What's driving the outbreak?
- Ashlee Simpson Shares the Secret to Her and Evan Ross' Decade-Long Romance
- In ‘Nickel Boys,’ striving for a new way to see
- After Roe: A New Battlefield (2022)
Ranking
- Chuck Scarborough signs off: Hoda Kotb, Al Roker tribute legendary New York anchor
- Are masks for the birds? We field reader queries about this new stage of the pandemic
- Shift to Clean Energy Could Save Millions Who Die From Pollution
- Financial Industry Faces Daunting Transformation for Climate Deal to Succeed
- Newly elected West Virginia lawmaker arrested and accused of making terroristic threats
- The 33 Most Popular Amazon Items E! Readers Bought This Month
- What Happened to Natalee Holloway: Breaking Down Every Twist in the Frustrating Case
- Lawyers fined for filing bogus case law created by ChatGPT
Recommendation
Jorge Ramos reveals his final day with 'Noticiero Univision': 'It's been quite a ride'
Kate Spade 24-Hour Flash Deal: Get This $300 Crossbody Bag for Just $69
Testosterone is probably safe for your heart. But it can't stop 'manopause'
Canada’s Struggling to Build Oil Pipelines, and That’s Starting to Hurt the Industry
Meta donates $1 million to Trump’s inauguration fund
Shawn Mendes and Camila Cabello Make Our Wildest Dreams Come True at Taylor Swift's Eras Tour
Honeybee deaths rose last year. Here's why farmers would go bust without bees
FDA approves a new antibody drug to prevent RSV in babies